{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T10:58:19Z","timestamp":1772967499375,"version":"3.50.1"},"reference-count":19,"publisher":"S. Karger AG","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis"],"published-print":{"date-parts":[[2013]]},"abstract":"<jats:p>Treatment of gastric marginal zone B cell lymphoma of MALT (mucosa-associated lymphoid tissue) is nowadays standardized as outlined in the German S3 guideline of 2009 and the European (EGILS) consensus report of 2011. The first choice of treatment is &lt;i&gt;Helicobacter pylori&lt;\/i&gt; eradication in any case irrespective of &lt;i&gt;H. pylori&lt;\/i&gt; status and lymphoma stage. Some 70-80% of patients reveal complete remission of MALT lymphoma following successful eradication of the bacterium. Those patients with histologically persisting lymphoma residuals are managed by a watch-and-wait strategy. Nonresponders to &lt;i&gt;H. pylori&lt;\/i&gt; eradication are referred to radiation with a curative intention in stages I and II. The rare cases of MALT lymphoma of stage III and IV should be treated by chemotherapy. Surgery no longer plays a role in the therapy of gastric MALT lymphoma except for very rare complications such as perforation or bleeding that cannot be controlled endoscopically. Diffuse large B cell lymphoma (DLBCL) is the second most common gastric lymphoma. &lt;i&gt;H. pylori&lt;\/i&gt; eradication may lead to regression of DLBCL in the individual case. However, immunochemotherapy by a combination of rituximab and the CHOP protocol represents the standard treatment approach in patients with DLBCL and offers a good curative chance.<\/jats:p>","DOI":"10.1159\/000347176","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T08:30:33Z","timestamp":1371544233000},"page":"38-42","source":"Crossref","is-referenced-by-count":12,"title":["MALT Lymphoma: Forget Surgery?"],"prefix":"10.1159","volume":"31","author":[{"given":"Wolfgang","family":"Fischbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2013,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s001080050635"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70028-3"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.19579"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.031"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.085"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.224949"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1109855"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-9-145"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1246012"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.07.017"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.083022"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31816a48f8"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.096420"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.085"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300495"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000129354.31318.f1"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.0722"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji277"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-404194"}],"container-title":["Digestive Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/347176","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/347176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:53:29Z","timestamp":1745434409000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000347176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,6,1]]},"published-print":{"date-parts":[[2013,6,18]]}},"URL":"https:\/\/doi.org\/10.1159\/000347176","archive":["Portico"],"relation":{},"ISSN":["0257-2753","1421-9875"],"issn-type":[{"value":"0257-2753","type":"print"},{"value":"1421-9875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}